Speakers

Speakers

Paul Alloway

Vice President & Head of Legal
Foghorn Therapeutics (Cambridge, MA)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 • 8:45 am

Greg Bell

Group Vice President and Life Sciences Practice Leader
Charles River Associates (Boston, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 • 9:00 am

Matt Blischak

Vice President, Intellectual Property Counsel
Roivant Sciences, Inc. (New York, NY)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Nicholas Boivin

Chief Intellectual Property Counsel
Forma Therapeutics (Watertown, MA)

Data Rooms with a View: Eyeing E-room Strategies for IP Due Diligence Projects

November 30, 2018 • 11:15 am

Ralph W. Carmichael

Chairman & Chief Executive Officer
BŌNWRx Ltd. (Lansing, MI)

Money Talks — Venture Capitalist Spotlight with:

November 30, 2018 • 8:15 am

Catherine Eckenswiller

Legal Counsel – Intellectual Property & Agreements
VBI Vaccines Inc. (Ottawa, CA)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 • 9:45 am

Jeffrey J. Ellison, Ph.D.

Partner
Clark + Elbing LLP (Boston, MA)

Data Rooms with a View: Eyeing E-room Strategies for IP Due Diligence Projects

November 30, 2018 • 11:15 am

Alysia A. Finnegan, Ph.D., Esq.

Counsel, Intellectual Property Group
Merck & Co. Inc. (Rahway, NJ)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Geoffrey Taylor Gibbs

Deputy General Counsel, Business, Finance and Innovation
University of California, Office of the President (Oakland, CA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 • 9:00 am

Kimya Harris, Ph.D.

Vice President, Head of Intellectual Property and Legal Affairs
KSQ Therapeutics (Cambridge, MA)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 • 9:45 am

Drew Holmes, Ph.D.

Senior Patent Attorney
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Pointing the Finger: When Defective IP Due Diligence Wrecks the Deal

November 30, 2018 • 12:00 pm

Thomas L. Irving

Partner
Finnegan Henderson Farabow Garrett & Dunner LLP (Washington, DC)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Brenda Jarrell, Ph.D.

Co-Chair of Intellectual Property and Life Sciences
Choate, Hall & Stewart LLP (Boston, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 • 9:00 am

Philip Johnson

Former Senior VP for IP Policy & Strategy
Johnson & Johnson (New Brunswick, NJ)

Fireside Chat on Global Factors Influencing IP Due Diligence with:

November 30, 2018 • 10:30 am

Mark D. Kafka

Associate Director, Assistant General Counsel
Genentech, Inc. (South San Francisco, CA)

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 • 1:15 pm

Lacy Kolo, Ph.D.

Director, Tech and IP Advisory
Houlihan Lokey (McLean, VA)

Decision Drivers — The Private Equity Perspective with:

November 29, 2018 • 2:30 pm

John Krayacich

Vice-President & Head, Business Development & Licensing
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 • 11:15 am

Forrester J. Liddle Ph.D., J.D.

Director of Intellectual Property
Jounce Therapeutics (Cambridge, MA)

The Best Things in Life are NOT Free: Assessing the Intricacies of Deal-Related IP Valuation

November 30, 2018 • 9:00 am

Jane M. Love, Ph.D.

Partner
Gibson, Dunn & Crutcher LLP (New York, NY)

Pointing the Finger: When Defective IP Due Diligence Wrecks the Deal

November 30, 2018 • 12:00 pm

Donna Meuth

Associate General Counsel – Intellectual Property
Eisai Inc. (Andover, MA)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 • 8:45 am

Mercedes K. Meyer, Ph.D., J.D.

Partner
Drinker Biddle & Reath LLP (Washington, DC)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

The Honorable Paul R. Michel (Ret.)

Former Chief Judge
United States Court of Appeals for the Federal Circuit (Alexandria, VA)

Fireside Chat on Global Factors Influencing IP Due Diligence with:

November 30, 2018 • 10:30 am

Ahmed Mousa, J.D.

Vice President, Licensing, IP & Legal Affairs
Pieris Pharmaceuticals Inc. (Boston, MA)

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 • 1:15 pm

Ryan Murphey

Counsel
Ropes & Gray LLP (New York, NY)

Will the Real Inventors Please Stand Up: Ensuring Proper Inventorship in an IP Due Diligence Analysis

November 29, 2018 • 9:45 am

Melanie R. Rupert

Partner, Life Sciences IP Litigation Global Co-Chair, Talent Development
Paul Hastings (New York, NY)

Realities and Illusions of Patent Strength: Analyzing Legal Developments Impacting IP Validity

November 29, 2018 • 8:45 am

Alicia A. Russo

Partner
Venable Fitzpatrick

Sizing up the Competition: Conducting Thorough and Cost-Efficient Freedom to Operate Analyses

November 29, 2018 • 1:15 pm

Jennifer Zarutskie Sieczkiewicz

Vice President, Chief Intellectual Property Counsel
Wave Life Sciences (Cambridge, MA)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Len Smith

Principal Counsel and Co-Founder
Transformative Legal (Scottsdale, AZ)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Gary J. Speier

Shareholder
Carlson Caspers Vandenburgh Lindquist & Schuman, PA (Minneapolis, MN)

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Ha Kung Wong

Due Diligence Head CM and NS
Venable Fitzpatrick

Be in the Room Where it Happens: Knowing how to Effectively and Successfully Communicate with the IP Due Diligence Team

November 29, 2018 • 3:45 pm

Frederick K. Young, Ph.D.

Due Diligence Head CM and NS
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Examining the Due Diligence Inner Sanctum

November 29, 2018 • 11:15 am